Four Days. Four Companies. A Bigger, Dedicated Stage for Healthcare Innovation During JPM 2027 In San Francisco.

Vista Partners’ sister company, Tribe Public (www.TribePublic.com), is expanding its CEO Presentation & Q&A Luncheon series during the annual J.P. Morgan Healthcare Conference (JPM2027) in San Francisco, the largest and most informative healthcare investment symposium in the industry. Tribe Public is now hosting four corporate-sponsored, RSVP-only Tribe Public CEO Presentation and Q&A Luncheon Events January 11-14. Tribe Public’s curated events will be taking place daily from noon to 2 p.m. at a location that is a short 5-minute Waymo to Uber ride from the conference. Each luncheon event is expected to welcome 50–80 attendees from the dedicated Tribe Public community that will, most likely, not be attending the chaos of other J.P. Morgan Healthcare Conference activities. However, the events or ‘company dedicated conferences’, will be meaningful and with thoughtful crowd that will help any company seeking to maximize their time and efforts to increase awareness, business development, and understanding amongst a broader globally connected community. One company will take center stage each day, giving its CEO a focused opportunity to share the company’s vision, highlight its latest developments and growth opportunities, and engage directly with a curated audience of Tribe Members through a live Q&A. For participating companies, this expanded series offers a compelling platform to elevate visibility, build relationships, and bring their stories to an engaged audience during a major week for healthcare. If companies are interested in presenting at one of these four events, then they should send an indication of interest to Events@TribePublic.com to schedule an introductory virtual meeting.

A Global Community. A Collective Voice. Direct Access.

Tribe Public aggregates the voices of consumers and investors to attract management teams from some of the world’s most interesting and groundbreaking companies to its corporate-sponsored, RSVP-only CEO presentations, Q&A luncheons, dinners, speaking engagements, and webinars. This growing community now spans 31 countries and is accessed via its ongoing Tribe Public CEO Presentation and Q&A Webinar based event series. Tribe Public also hosts luncheon, dinner, and speaking engagement events across 41 Tribe Event Venues in the United States. Members regularly learn alongside one another and engage directly with company leadership and experts. The Tribe Public audience includes portfolio managers from large and small funds, registered investment advisors, family offices, accredited investors, business owners, retail traders, brokers, sell-side analysts, entrepreneurs, and members of the media. This diverse community brings thoughtful questions and a broad range of perspectives to every conversation.

Capital-Markets Expertise. An Integrated Communications Platform.

Vista Partners LLC is a California-registered investment advisor with capital-markets and strategic-advisory capabilities. Its focus complements the opportunity for companies to communicate their vision, articulate their growth strategies, and build meaningful relationships with the investment community. Vista is led by its Managing Member, John F. Heerdink, Jr, an advisor, investor and entrepreneur, who has advised public and private companies across all sectors with an emphasis on biotechnology, healthcare, technology & natural resource companies. In addition, Mr. Heerdink has worked with companies seeking a listing on public exchanges via IPO, reverse merger and assisted foreign issuers seeking a listing on a U.S. exchange. Mr. Heerdink has assisted companies to raise debt and equity capital for growth, consummated mergers and acquisitions, and performed all other matters dealing with investor relations, business development, & marketing. He maintains an extensive relationship base in the investment community, lending industry, investment banking industry & a worldwide investor network. Learn more about Vista Partners: www.vistapglobal.com/about-vista-partners/.

Tribe Public LLC is an integrated media, communications, and investor-event platform that supports live experiences, digital events, original content development, social distribution, and targeted outreach. These capabilities create opportunities to extend company storytelling beyond a single presentation and support continued audience engagement. Learn more about Tribe Public: www.TribePublic.com.

With an expanded four-day luncheon series and a growing global community, Tribe Public is creating more opportunities for healthcare leaders to tell their stories, and for investors and consumers to hear directly from the people shaping what comes next. if you would care to join these upcoming events, then please join the Tribe by registering at www.TribePublic.com and or send a message to Events@TribePublic.com. If you are a company CEO or Director of Investor Relations that would like to learn more and/or even to be considered to be a presenter during the J.P Morgan Healthcare Week in San Francisco or otherwise across the U.S., then please send a request to Research@TribePublic.com.

JPM 2026 Tribe Presenters Prospered

In January 2026 during the JPMorgan Healthcare Conference Week, two biotech companies, Alpha Cognition Inc. (NASDAQ: ACOG) & Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX; TSX: EPRX), presented at Tribe Public CEO Luncheon Events in San Francisco and have been quite successful in the clinic, commercially, raising significant capital, attracting a wider audience of investors, consumers, sell-side coverage, while The Vista Partners – Tribe Public Platform helped enhance their corporate development, IR, PR and marketing efforts.

Alpha Cognition Inc. (NASDAQ: ACOG) has moved meaningfully beyond the familiar small-cap biotech ritual of promising future potential. Since CEO Michael McFadden’s January 15, 2026 Tribe Public CEO luncheon presentation during the J.P. Morgan Healthcare Conference week in San Francisco, the company has paired its Alzheimer’s commercial launch with accelerating prescription metrics, a growing clinical-evidence program and strengthened European intellectual-property protection. The market has noticed. ACOG closed at $5.82 on January 15, 2026 and $9.52 on September 4, 2026, an increase of approximately 63.6%. That compares with a 46.5% year-to-date return reported by Yahoo Finance as of September 4. At the Tribe Public CEO luncheon in San Francisco, Alpha Cognition’s case centered on the commercial opportunity for ZUNVEYL®, its FDA-approved oral treatment for mild-to-moderate Alzheimer’s disease, and the possibility that differentiated tolerability could matter in a market where caregivers, clinicians and patients have little appetite for avoidable complexity. Since then, the company has produced the sort of operating evidence investors generally prefer to PowerPoint optimism: revenue, prescription growth, repeat physician engagement and rising long-term-care penetration. Small-cap biotech shares are rarely accused of moving in a straight line, but ACOG’s direction has become increasingly difficult to mistake.

Since Founder and CEO James Helliwell M.D. presented at their own Tribe Public CEO luncheon event during the J.P. Morgan Healthcare Conference week in January 2026, Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX; TSX: EPRX) has prospered and the stock has establish a new 52-week high of $9.32. Recently, Eupraxia added a new layer of clinical durability to its EoE investment case, and Wall Street’s bullish coverage is becoming harder to overlook. The company’s latest 52-week EP-104GI data, including 64% clinical remission among evaluable higher-dose patients after a single administration, arrive as analysts publish price targets ranging from $11 to $25 and investors focus on a pivotal near-term event: interim data from the randomized, placebo-controlled RESOLVE Phase 2b study expected in December 2026.

Join The Tribe In Nashville October 13, 2026

If you have not attended one of Tribe Public’s dinners or luncheon events across its 41 U.S. event venues, the format is designed to offer RSVP-only, corporate-sponsored access to management teams and industry experts across a broad range of sectors and investment interests. The gatherings bring together family offices, portfolio managers, accredited investors, business owners, media professionals, and community members interested in hearing directly from corporate leaders while sharing a complimentary, time-efficient private meal. More information is available at Tribe Public.

Tribe Public’s next Nashville corporate-sponsored CEO presentation and Q&A dinner, “Precision Matters: Discover How The Future Of Drug Delivery Is Local,” is scheduled for Tuesday, October 13, from 6:00–8:00 PM at the private room at Ruth’s Chris Steak House, 2100 West End Avenue, Nashville, Tennessee 37203.

The evening will feature James A. Helliwell, M.D., Co-Founder, Chief Executive Officer, and Director of Eupraxia Pharmaceuticals (NASDAQ: EPRX; TSX: EPRX). Attendees will have an opportunity to hear directly from Dr. Helliwell about Eupraxia’s precision drug-delivery strategy, its inflammatory-disease clinical focus, and the company’s approach to pursuing localized, extended-release therapies.

About The Speaker. Dr. Helliwell is a board-certified cardiac anesthesiologist and former Assistant Clinical Professor at the University of British Columbia. He founded Eupraxia based on the view that the right medicine, delivered to the right place at the right dose and for the right duration, can improve patient outcomes. His work has appeared in journals including The Lancet Rheumatology, Gastroenterology, and Osteoarthritis & Cartilage. He also founded Accuro Technology, developer of the FDA-approved Arthrotap device, later acquired by Elcam Medical; co-founded Thrive Health; and holds eight granted patents and 35 pending patents related to drug and device delivery.

About The Company. Eupraxia is a clinical-stage biotechnology company advancing localized, extended-release therapies through its proprietary Diffusphere platform. Its lead program, EP-104GI, is in Phase 1b/2 development for EoE, a chronic inflammatory disease in which eosinophils infiltrate the esophagus and can contribute to difficulty or pain with swallowing, food impactions, anxiety, depression, and longer-term esophageal remodeling or strictures.

Space is limited. To reserve a seat, or request seating for friends, family members, or colleagues, email Events@TribePublic.com.

The New Premium Asset: Attention That Shows Up

In an era when nearly every company can publish a deck, record a webcast and summon an algorithmic audience, the scarce asset is becoming more human: a room, or a virtual room, filled with people who actually care enough to listen, ask questions and return. That is the environment in which Tribe Public (www.TribePublic.com) is positioned to thrive: transforming investor and consumer interest into direct access to company leadership, one CEO conversation at a time.

The Return of the Room

A growing group of prominent entrepreneurs is building businesses around an observation that would have seemed suspiciously analog only a few years ago: people want to be together again. TechCrunch recently highlighted this emerging “togetherness” economy through companies such as Board, founded by Mirror creator Brynn Putnam; Heirloom Craft, led by Walker & Company founder Tristan Walker; Pie, from Bonobos founder Andy Dunn; and Six Bells, the Hudson Valley hospitality venture founded by Audrey Gelman. Their businesses differ, social gaming, skilled-trade education, community software and immersive hospitality, but share a common wager: thoughtfully designed experiences can create durable value by helping people reconnect. The underlying demand is more than a lifestyle headline. The World Health Organization says roughly one in six people globally experiences loneliness, with material implications for health, well-being and society. Meanwhile, a Harris Poll survey commissioned by Marriott Bonvoy found 67% of Americans planned to prioritize experiences, including travel, over material goods in 2026. That backdrop matters to markets because experience-driven engagement is not merely discretionary entertainment. It is becoming a form of infrastructure: relationship infrastructure, information infrastructure and, increasingly, investor-access infrastructure. Learn More Now.